Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Book;
Konferenzbericht
Titel:
Intraperitoneal Cancer Therapy
Enthält:
Front Matter; Management of Ovarian Cancer: The Theory; Management of Ovarian Cancer: Clinical Trials; A Systematic Review and Meta-Analysis of Randomized Trials; Immunobiology and Intraperitoneal Immunobiologics in Ovarian Cancer; Intraperitoneal Chemotherapy: Technique and Complications; Hyperthermia and Chemotherapy: The Science; Hyperthermic Intraperitoneal Chemotherapy in Nongynecologic Cancers; Peritoneal Carcinomatosis of Colorectal Origin; Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: Experience in France
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World ExperienceTechniques of Delivering Hyperthermic Intraperitoneal Chemotherapy; Future Directions in the Delivery of Hyperthermic Intraperitoneal Chemotherapy; Back Matter
Anmerkungen:
Includes bibliographical references and index
Beschreibung:
This book investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. The future direction of intraperitoneal chemotherapy both normothermic and hyperthermic is also covered.
Intraperitoneal Cancer Therapy investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ovarian cancers. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other chapters also investigate techniques and procedures in treatment, as well as the future direction of both normothermic and hyperthermic intraperitoneal chemotherapy.